Home > Insider Trading > Filing (0001179110-13-015259)

Filing Details

Accession Number:: 0001179110-13-015259
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-03 17:51:41
Reporting Period:: 2013-09-30

Filing Date:: 2013-10-03
Accepted Time:: 2013-10-03 17:51:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410939	Ophthotech Corp.	OPHT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1232258	Ltd. (Cayman) Investments Healthcare Hbm	Governors Square, Suite #4-212-2 23 Lime Tree Bay Ave., West Bay Grand Cayman E9 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-09-30	2,806,937	$0.00	2,806,937	No	4	C	Direct
Common Stock	Acquisiton	2013-09-30	398,208	$0.00	3,205,145	No	4	C	Direct
Common Stock	Acquisiton	2013-09-30	206,756	$0.00	3,411,902	No	4	C	Direct
Common Stock	Acquisiton	2013-09-30	228,000	$22.00	3,639,902	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-09-30	2,806,937	$0.00	2,806,937	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-09-30	398,208	$0.00	398,208	$0.00
Common Stock	Series C Preferred Stock	Disposition	2013-09-30	206,756	$0.00	206,756	$0.00
Common Stock	Series A Preferred Stock Warrant	Disposition	2013-09-30	13,670	$0.00	13,670	$0.00
Common Stock	Common Stock Warrant	Acquisiton	2013-09-30	13,670	$0.00	13,670	$0.06

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Direct
0		No	4	C	Direct
0		No	4	C	Direct
0	2017-06-18	No	4	C	Direct
13,670	2017-06-18	No	4	C	Direct

Footnotes

Each share of Series A Preferred Stock automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the Issuer's firm commitment underwritten public offering pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO") and had no expiration date.
Each share of Series B Preferred Stock automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the Issuer's IPO and had no expiration date.
Each share of Series C Preferred Stock automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the Issuer's IPO and had no expiration date.
Includes 370,591 shares of Common Stock issued upon the closing of the Issuer's IPO for stock dividends that accrued on the Series A Preferred Stock prior to conversion.
Includes 45,101 shares of Common Stock issued upon the closing of the Issuer's IPO for stock dividends that accrued on the Series B Preferred Stock prior to conversion.
Includes 1,782 shares of Common Stock issued upon the closing of the Issuer's IPO for stock dividends that accrued on the Series C Preferred Stock prior to conversion.
The Series A Preferred Stock Warrant converted to a Common Stock Warrant in connection with the closing of the Issuer's IPO. The number of shares of the Common Stock Warrant includes an adjustment to account for additional shares of Common Stock issued as accrued stock dividends in connection with the closing of the issuer's IPO.
Immediately exercisable.
Pursuant to the issuer's fourth amended and restated certificate of incorporation as amended, all shares of the Issuer's preferred stock were aggregated across series for purposes of conversion to Common Stock resulting in an additional whole share being issued as a result of the aggregation of fractional shares across series.